Skip to main content

ERRATUM article

Front. Pharmacol., 09 February 2023
Sec. Cardiovascular and Smooth Muscle Pharmacology
Volume 14 - 2023 | https://doi.org/10.3389/fphar.2023.1154384

Erratum: SIRT1 activation and its effect on intercalated disc proteins as a way to reduce doxorubicin cardiotoxicity

This article is an erratum on:

  1. SIRT1 activation and its effect on intercalated disc proteins as a way to reduce doxorubicin cardiotoxicity

    1. Read original article
Frontiers Production Office Frontiers Production Office*
  • Frontiers Media SA, Lausanne, Switzerland

An erratum on:
SIRT1 activation and its effect on intercalated disc proteins as a way to reduce doxorubicin cardiotoxicity

by Podyacheva, E., and Toropova, Y. (2022). Front. Pharmacol. 13, 1–23. doi: 10.3389/fphar.2022.1035387

Due to a production error, the reference for “Ito et al., 2021” was incorrectly written as “Ito, Y., Yoshida, M.,Masuda, H.,Maeda, D., Kudo-Asabe, Y., Umakoshi,M., et al. (2021). Neovasculature can be induced by patching an arterial graft into a vein: A novel in vivo model of spontaneous arteriovenous fistula formation. Sci. Rep. 11, 3156–3213. doi:10.1038/s41598-018-21535-2”. It should be “Ito, Y., Yoshida, M., Masuda, H., Maeda, D., Kudo-Asabe, Y., Umakoshi, M., et al. (2021). Disorganization of intercalated discs in dilated cardiomyopathy. Sci. Rep. 11, 1–13. doi: 10.1038/s41598-021-90502-1”.

The publisher apologizes for this mistake. The original version of this article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: adherens junctions, desmosomes, doxorubicin cardiomyopathy, gap junction, heart failure, intercalated discs, NAD+, sirtuins

Citation: Frontiers Production Office (2023) Erratum: SIRT1 activation and its effect on intercalated disc proteins as a way to reduce doxorubicin cardiotoxicity. Front. Pharmacol. 14:1154384. doi: 10.3389/fphar.2023.1154384

Received: 30 January 2023; Accepted: 30 January 2023;
Published: 09 February 2023.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2023 Frontiers Production Office. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Frontiers Production Office, production.office@frontiersin.org

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.